Same Indication

Pembrolizumab vs Spironolactone

Pembrolizumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Spironolactone.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone — C24H32O4S.

Molecular Weight: Spironolactone — 416.5740 g/mol.

Type: Pembrolizumab — Antibody; Spironolactone — Small molecule.